Clarcor, Transcept: After-Hours Trading

NEW YORK ( TheStreet) -- Shares of Clarcor ( CLC) slumped in late trades Wednesday after the Franklin, Tenn.-based maker of filtration and industrial products fell short of Wall Street expectations with its fiscal third-quarter results.

The company posted a profit of $32.1 million, or 63 cents a share, for the three months ended in August on revenue of $284.8 million, up from its year-ago equivalent earnings of $28.3 million, or 55 cents a share, on revenue of $262.8 million, but below the average estimate of analysts polled by Thomson Reuters for earnings of 66 cents a share in the August period on revenue of $295.3 million.

Clarcor acknowledged that its business in China was less robust than anticipated in the quarter but stood by a year-end goal.

"The slowdown in China in the third quarter was the result of softer demand from our OEM first-fit customers as they adjusted their production schedules," said Norm Johnson, the company's chairman and CEO. "We expect a return to higher growth in China in the fourth quarter and still expect our China heavy-duty engine filter sales to grow approximately 30% for the full year--our original target for 2011."

The stock was last quoted at $42, down 8.4%, on volume of around 16,000, according to Nasdaq.com. Based on a regular session close at $45.84, the shares were up nearly 6% so far in 2011.

The company's gross margin of 33.7% was below its year-ago performance, which Clarcor's Johnson attributed to "additional costs that we incurred to launch a new air filtration product and a higher sales mix of capital vessels versus aftermarket filters in our natural gas market."

Clarcor maintained its outlook for earnings of $2.25 to $2.40 a share for 2011, and said it expects profits to come in at the upper end of this range assuming no major economic disruptions in its fiscal fourth quarter ending in November. However the company added that it's entered the fourth quarter with "some caution."

"We experienced some challenges with slower economic activity in Europe and China in the third quarter, and uncertainty prevails in the U.S. economy going forward," Johnson said.

Transcept Pharmaceuticals

A big mover to the upside late Wednesday was Transcept Pharmaceuticals ( TSPT), whose stock soared after the company announced a plan to resubmit the new drug application for its proposed insomnia drug Intermezzo by the end of the month.

The shares jumped 13.8% to $3.80 on extended-session volume of almost 280,000.

Transcept is seeking approval for the tablet "for use as-needed for the treatment of insomnia when a middle of the night awakening is followed by difficulty returning to sleep." The plan to resubmit the application follows the company meeting with the FDA and reaching a general agreement with the regulator to reduce the recommended dosage for women to 1.75 milligrams from 3.5 milligrams, while leaving the 3.5 milligram dosage in place for men.

The company added that, based on its discussions with the FDA, it doesn't expect to conduct additional clinical studies of Intermezzo prior to resubmitting the new drug application. It also proposes to include additional instructions on safe usage of the drug.

Another stock in action after the close included Ascena Retail Group ( ASNA), whose stock lost 8% to $25.96 on volume of more than 30,000 after the Suffern, N.Y.-based company's fiscal fourth-quarter earnings came in a penny short of analyst expectations.

-- Written by Michael Baron in New York.

Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.

More from Opinion

Tuesday Turnaround in Politics: Is a Trade War on the Horizon?

Tuesday Turnaround in Politics: Is a Trade War on the Horizon?

Many Chip Stocks Look Cheap Here, as Long as the Economy Holds Up

Many Chip Stocks Look Cheap Here, as Long as the Economy Holds Up

3 Warren Buffett Stock Picks That Could Be Perfect for Your Retirement Portfolio

3 Warren Buffett Stock Picks That Could Be Perfect for Your Retirement Portfolio

Apple Buys Tesla? Amazon Buys Sears? 3 Dream Mergers That Just Make Sense

Apple Buys Tesla? Amazon Buys Sears? 3 Dream Mergers That Just Make Sense

50 Stocks That Could Be Shredded If a U.S. Trade War With China Ignites

50 Stocks That Could Be Shredded If a U.S. Trade War With China Ignites